SPDR S&P Biotech (XBI)

Add to Watchlists
Create an Alert
217.44 +2.81  +1.31% NYSE Arca Mar 2, 4:59PM BATS Real time Currency in USD
View Full Chart
XBI Price Chart

XBI Description

SPDR S&P Biotech is a long only equity fund managed by SPDR State Street Global Advisors that tracks the S&P Biotechnology Select Industry TR USD index and has 2.079B USD assets under management. It has an expected distribution yield of 0.92%, a Forecasted PE Ratio of 29.42, and a Forecasted Price to Book Value of 5.822. The fund has a net expense ratio of 0.35%, turns over its positions 86.00% per year, and is traded on the New York Stock Exchange Arca.

XBI Key Info

Expense Ratio (2-3-15) 0.35%
Assets Under Management (3-2-15) 2.079B
30-Day Average Volume (2-27-15) 755441.8
Net Asset Value (2-27-15) 214.57
Discount or Premium to NAV (2-26-15) 0.00%
Turnover Ratio (6-30-14) 86.00%

XBI Asset Allocation

Type % Net % Long % Short
Cash 0.02% 0.02% 0.00%
Stock 99.98% 99.98% 0.00%
Bond 0.00% 0.00% 0.00%
Convertible 0.00% 0.00% 0.00%
Preferred 0.00% 0.00% 0.00%
Other 0.00% 0.00% 0.00%
As of Feb. 27, 2015

XBI Region Exposure

Americas 97.42%
North America 97.42%
Latin America 0.00%
Greater Europe 2.58%
United Kingdom 0.00%
Europe Developed 2.58%
Europe Emerging 0.00%
Africa/Middle East 0.00%
Greater Asia 0.00%
Japan 0.00%
Australasia 0.00%
Asia Developed 0.00%
Asia Emerging 0.00%
Market Classification
% Developed Markets 100.0%
% Emerging Markets 0.00%
As of Feb. 27, 2015
Region breakdown data is calculated by using the long position holdings of the portfolio.

XBI Stock Sector Exposure

Basic Materials 0.00%
Communication Services 0.00%
Consumer Cyclical 0.00%
Consumer Defensive 0.00%
Energy 0.00%
Financial Services 0.00%
Healthcare 100.0%
Industrials 0.00%
Real Estate 0.00%
Technology 0.00%
Utilities 0.00%
As of Feb. 27, 2015

XBI Stock Market Capitalization

Giant 4.37%
Large 4.42%
Medium 17.75%
Small 34.51%
Micro 38.92%
As of Feb. 27, 2015
View More Holdings

XBI Top 10 Holdings

Name % Weight Price Chg %
Exelixis Inc 2.18% 3.08 +5.12%
Foundation Medicine Inc 2.11% 48.35 +1.24%
Halozyme Therapeutics Inc 1.96% 15.22 +1.00%
Opko Health Inc 1.85% 14.43 -0.89%
Neurocrine Biosciences Inc 1.85% 40.43 +3.53%
Pharmacyclics Inc 1.69% 221.12 +2.41%
Intercept Pharmaceuticals Inc 1.67% 225.34 +1.79%
Novavax Inc 1.65% 8.915 -2.57%
Intrexon Corp 1.58% 42.98 +4.68%
Tesaro Inc 1.48% 54.33 +1.88%
As of Feb. 27, 2015
Get Quote for
Advertisement

XBI Basic Info

Style
Broad Asset Class Sector Equity
Broad Category Equity
Prospectus Objective Specialty - Health
Fund Owner Firm Name SPDR State Street Global Advisors
Benchmark Index
S&P Biotechnology Select Industry TR USD 100.0%
Key Dates
Inception Date 1/31/2006
Last Annual Report Date 6/30/2014
Last Prospectus Date 2/3/2015
Attributes
Exchange Traded Share Yes
Exchange Traded Note No
Enhanced Index Fund No
Index Fund Yes
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan Yes
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available RRSP No

XBI Manager Info

Name Tenure
John Tucker 9.01 yrs
Karl Schneider 0.25 yrs
Michael Feehily 3.26 yrs

XBI Risk Info

Beta 1.105
30 Day Average Volatility 29.32%

XBI Fundamentals

Dividend Yield TTM (3-2-15) 0.92%
Weighted Average PE Ratio --
Weighted Average Price to Sales Ratio 14.19
Weighted Average Price to Book Ratio 7.331
Weighted Median ROE -18.30%
Weighted Median ROA -25.23%
Forecasted Dividend Yield 0.02%
Forecasted PE Ratio 29.42
Forecasted Price to Sales Ratio 7.461
Forecasted Price to Book Ratio 5.822
Number of Holdings 85.00
As of Feb. 27, 2015

XBI Growth Estimates

Forecasted 5 Yr Earnings Growth 18.65%
Forecasted Book Value Growth 6.74%
Forecasted Cash Flow Growth 13.04%
Forecasted Earnings Growth 33.84%
Forecasted Revenue Growth 0.28%
As of Feb. 27, 2015

XBI Performance

  Returns Total Returns
1M 6.24% 6.24%
3M 20.46% 20.77%
6M 34.08% 34.91%
1Y 27.41% 28.98%
3Y 178.6% 183.2%
5Y 286.1% 292.5%
As of Feb. 27, 2015

XBI Flows

1M 163.83M
3M 452.02M
6M 447.77M
YTD 414.22M
1Y 259.58M
3Y 596.58M
5Y 491.57M
As of Feb. 28, 2015
Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 7-Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.